Pharma Focus Asia

Eminence Biotechnology Opens New Manufacturing Facility in China

Introduction:

Eminence Biotechnology opens a new state-of-the-art production facility in Suzhou Industrial Park, China

Features:

The new facility is designed with advanced vertical pin-milling technology and top-notch utility systems.

The opening of the new facility will address the requirements for premium-quality cell culture media across a spectrum of critical sectors, including vaccines, gene therapies, cell therapies, antibodies, and recombinant proteins.

The new facility occupies approximately 7,000 square metres. The facility has been thoughtfully designed to encompass dedicated zones for different operational functions. These zones include areas for media production, warehousing, and laboratory functions, ensuring efficient and streamlined processes.

The facility boasts an impressive production capacity, featuring three dry powder production lines and two liquid production lines. The the facility proudly achieves an annual production capacity of an impressive 20 million litres of dry powder media and 300,000 litres of liquid media.

Specifications:

Name   Eminence Biotechnology

Type   Opening of New Facility

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024